Polycystic Ovary Syndrome Market By Treatment Type (Medication [Oral Contraceptives, Anti-Androgens, Insulin-Sensitizing Agents, Gonadotropins, and Fertility Drugs], Surgery [Ovarian wedge resection, Laparoscopic ovarian drilling, and Other surgeries], and Others), By Drug Class (Hormonal Drugs, Anti-diabetics, Anti-obesity Drugs, and Anti-depressants), By Diagnosis (Ultrasound, Blood Tests, Physical Examination, and Pelvic Exam), and By End-User (Hospitals, Fertility Clinics, Ambulatory Surgical Centers, and Diagnostic Centers) Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Report Coverage:

By Treatment Type

• Medication
  • Oral Contraceptives
  • Anti-Androgens
  • Insulin-Sensitizing Agents
  • Gonadotropins
  • Fertility Drugs
• Surgery
  • Ovarian wedge resection
  • Laparoscopic ovarian drilling
  • Other surgeries
• Others

By Drug Class

• Hormonal Drugs
• Anti-diabetics
• Anti-obesity Drugs
• Anti-depressants

By Diagnosis

• Ultrasound
• Blood Tests
• Physical Examination
• Pelvic Exam

By End-User

• Hospitals
• Fertility Clinics
• Ambulatory Surgical Centers
• Diagnostic Centers

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Teva Pharmaceutical Industries Ltd.
• Bayer AG
• Abbott Laboratories
• Merck & Co., Inc.
• Bristol-Myers Squibb
• Ferring Pharmaceuticals
• Sanofi S.A.
• AstraZeneca
• Novartis AG
• GlaxoSmithKline plc (GSK)
• Pfizer Inc.
• Takeda Pharmaceutical Company Limited
• Johnson & Johnson
• Sun Pharmaceutical Industries Ltd.
• Ipsen Pharma